Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) R&D In Process (2016 - 2023)

Historic R&D In Process for Fortress Biotech (FBIO) over the last 10 years, with Q4 2023 value amounting to $31000.0.

  • Fortress Biotech's R&D In Process fell 9524.54% to $31000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $4.3 million, marking a year-over-year increase of 48432.43%. This contributed to the annual value of $300000.0 for FY2024, which is 9306.2% down from last year.
  • Per Fortress Biotech's latest filing, its R&D In Process stood at $31000.0 for Q4 2023, which was down 9524.54% from $60000.0 recorded in Q3 2023.
  • Fortress Biotech's R&D In Process' 5-year high stood at $14.9 million during Q1 2020, with a 5-year trough of $1000.0 in Q2 2022.
  • For the 5-year period, Fortress Biotech's R&D In Process averaged around $2.2 million, with its median value being $454000.0 (2019).
  • Per our database at Business Quant, Fortress Biotech's R&D In Process soared by 320377.78% in 2020 and then crashed by 9999.09% in 2022.
  • Quarter analysis of 5 years shows Fortress Biotech's R&D In Process stood at $450000.0 in 2019, then grew by 23.56% to $556000.0 in 2020, then crashed by 92.81% to $40000.0 in 2021, then soared by 1530.0% to $652000.0 in 2022, then plummeted by 95.25% to $31000.0 in 2023.
  • Its R&D In Process was $31000.0 in Q4 2023, compared to $60000.0 in Q3 2023 and $3000.0 in Q2 2023.